Axe Compute Inc. (NASDAQ: AGPU) is a Technology company (Software - Infrastructure) with a market capitalization of $79M. The Maz Rating grades it against the other companies in its sector.
Axe Compute Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $6.97, Axe Compute Inc. trades at 7.5x sales and 3.2x book value, with an EV/EBITDA of 0.3. Over the last twelve months it generated about $11M of revenue and a net loss of $432M. It runs a gross margin of 3.7%, an operating margin of -200.0% and a net margin of -1564.9%. It shows return on equity of -390.6%, return on invested capital of -3.8% and a free cash flow yield of 279.8%. On the balance sheet: a debt-to-equity ratio of 0.65 and a current ratio of 1.33. Over the past 52 weeks the share price ranged from $1.03 to $13.49, with a beta of 3.83.
Axe Compute Inc. does not currently pay a dividend.
1 Wall Street analyst rating covers the stock: 1 Hold, for a Hold consensus. This is the sell side's view, separate from the Maz Rating.
Headquartered in Pittsburgh, Pennsylvania, Axe Compute Inc., established in 2002 and formerly known as Predictive Oncology Inc. until its December 2025 renaming, is an enterprise that leverages profound scientific insights and artificial intelligence (AI) to advance the discovery and development of cancer treatments. The company's operations are divided into two distinct segments. Its Pittsburgh division offers AI-driven services, utilizing an exclusive biobank containing over 150,000 tumor samples, and engineers specialized 3D cell culture models vital for drug advancement. Meanwhile, the Eagan division produces the FDA-approved STREAMWAY System and related products, which facilitate automated medical fluid waste management and direct patient-to-drain fluid disposal. Additionally, Axe Compute maintains a strategic partnership with Every Cure to identify and prioritize existing pharmaceuticals for repurposing.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.
It depends on the standard you follow. As of September 2026, Axe Compute Inc. (AGPU) passes 2 of 5 published Shariah screening standards checked by Maz Vantage: it passes MSCI and FTSE, and fails AAOIFI, S&P Global and Dow Jones.
| Standard | Ratios (value / limit) | Result |
|---|---|---|
| AAOIFI | Debt / Mkt Cap (36m) 15.3% / 30% · (Cash+Inv) / Mkt Cap (36m) 76.6% / 30% · Interest income / Revenue 0.00% / 5% | Fail |
| S&P Global | Debt / Mkt Cap (36m) 15.3% / 33% · (Cash+ST Inv) / Mkt Cap (36m) 75.6% / 33% · Receivables / Mkt Cap (36m) 7.37% / 49% · Interest income / Revenue 0.00% / 5% | Fail |
| Dow Jones | Debt / Mkt Cap (24m) 15.3% / 33.33% · (Cash+ST Inv) / Mkt Cap (24m) 75.6% / 33.33% · Receivables / Mkt Cap (24m) 7.37% / 33.33% · Interest income / Revenue 0.00% / 5% | Fail |
| MSCI | Debt / Avg Assets (4Q) 3.44% / 33.33% · (Cash+ST Inv) / Avg Assets (4Q) 21.2% / 33.33% · Receivables / Avg Assets (4Q) 4.82% / 33.33% · Interest income / Revenue 0.00% / 5% | Pass |
| FTSE | Debt / Total Assets 4.36% / 33.33% · (Cash+ST Inv) / Total Assets 21.5% / 33.33% · (Cash+Recv) / Total Assets 23.6% / 33.33% · Interest income / Revenue 0.00% / 5% | Pass |
It depends on the standard you follow. As of September 2026, Axe Compute Inc. (AGPU) passes 2 of 5 published Shariah screening standards checked by Maz Vantage: it passes MSCI and FTSE, and fails AAOIFI, S&P Global and Dow Jones.
No. Axe Compute Inc. is over the AAOIFI limit on (Cash+Inv) / Mkt Cap (36m).
Axe Compute Inc. reported no interest income in the latest quarter, so there is nothing to purify from its dividend on that basis.
The screen is rerun on each quarterly report; the figures here are from the balance sheet dated September 30, 2026 (Q3 2026). A status can change from one quarter to the next as debt, cash and market value move.
See also the list of halal stocks, halal tech stocks, the halal stock screener, the dividend purification calculator and the zakat calculator.
A mechanical screen of published financial ratios and the company's line of business, not a religious ruling. It does not test every revenue stream; check with a scholar you trust.